Cargando…
MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling
Colorectal cancer (CRC) is one of the most frequently diagnosed cancers worldwide. Development of novel chemotherapeutics is still required to enable successful treatment and improve survival for CRC patients. Here, we found that osimertinib (OSI) exhibits potent anti-CRC effects by inducing apoptos...
Autores principales: | Jin, Ping, Jiang, Jingwen, Xie, Na, Zhou, Li, Huang, Zhao, Zhang, Lu, Qin, Siyuan, Fu, Shuyue, Peng, Liyuan, Gao, Wei, Li, Bowen, Lei, Yunlong, Nice, Edouard C., Li, Changlong, Shao, Jichun, Xie, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692318/ https://www.ncbi.nlm.nih.gov/pubmed/31409796 http://dx.doi.org/10.1038/s41419-019-1844-2 |
Ejemplares similares
-
AMPK potentiation by LKB1 isoforms
por: Thibert, Chantal, et al.
Publicado: (2015) -
LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022) -
Connecting LKB1 and AMPK links metabolism with cancer
por: Moore, Pete
Publicado: (2003) -
MLK3 Phophorylates AMPK Independently of LKB1
por: Luo, Lingyu, et al.
Publicado: (2015) -
Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex
por: Xie, Liping, et al.
Publicado: (2022)